CARGO THERAPEUTICS INC (CRGX) Stock News
NASDAQ:CRGX - Nasdaq - US14179K1016 - Common Stock - Currency: USD
CRGX Latest News, Press Releases and Analysis
Let's take a look at the stocks that are in motion in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
There are notable gap-ups and gap-downs in today's session.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Stay updated with the stocks that are on the move in today's pre-market session.
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
Curious about the stocks that are showing activity after the closing bell on Wednesday?
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options...
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025...
Neue Möglichkeiten der Krebsbehandlung durch hochmoderne Immuntherapien
/PRNewswire/ -- USA News Group Nachrichtenkommentar – Die jüngsten Fortschritte in der Krebsbehandlung demonstrieren weiterhin das transformative Potenzial...
Les immunothérapies de pointe redéfinissent les options de traitement du cancer
/PRNewswire/ -- USA News Group News Commentary - Les récentes avancées dans le traitement du cancer continuent de souligner le potentiel transformateur des...
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options
/PRNewswire/ -- USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the transformative potential of innovative...
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference...
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update...
CARGO Therapeutics to Participate in Upcoming Investor Conferences
CARGO Therapeutics to Participate in Upcoming Investor Conferences
CARGO Therapeutics to Participate in Upcoming Investor Conferences...
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma...
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024
CRGX stock results show that Cargo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cargo Therapeutics (NASDAQ:CRGX) just reported results for the second quarter o...
Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week
Along with quarterly results, the clinical-stage company provided an encouraging business update.
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update ...
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet...